ArticlePhysiological reports2026
Eucalyptus cinerea phytoactive compounds alleviate pulmonary fibrosis by targeting oxidative stress, inflammation, and immune pathways in male rats.
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eucalyptus cinerea is known for anti-inflammatory/antioxidant properties in Tunisian traditional medicine, but research on its seeds for the treatment of pulmonary fibrosis (PF) is insufficient. The study investigated the phytochemical properties and the curative potential of Eucalyptus cinerea seeds aqueous extract (ECAE) against bleomycin (BLEO)-induced sub-acute experimental PF as well as the mechanisms implicated in such protection. Firstly, the phytochemical analysis of ECAE revealed the presence of 7 phenolic compounds, including 3 phenolic acids, 3 flavonoids, and 1 tannin. Results of the in vivo assay showed that ECAE treatment significantly reduced BLEO-induced lung lesions and improved histopathological alterations. ECAE attenuated BLEO-induced plasma and pulmonary lipid peroxidation and the depletion of both enzymatic and non-enzymatic antioxidants. More importantly, intratracheal instillation of BLEO increased hydrogen peroxide and calcium levels, while the ECAE treatment reversed all intracellular mediator perturbations. Also, ECAE exhibited anti-inflammatory and immunomodulatory properties. These results suggest that Eucalyptus cinerea seeds contain anti-inflammatory compounds that could help fight PF, making them a potential ingredient for functional foods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.